Vaccines are one of the fastest growing areas in cancer research, and one industry research firm projects that the market for personalized cancer vaccines could reach more than $8 billion a year by 2034. Former NBC News correspondent Kristen Dahlgren and cancer researcher Dr. Karen Knudsen, CEO of The Parker Institute, join TODAY to share the latest updates on where breast cancer vaccines stand and what it means for treatment in the future.